Your browser doesn't support javascript.
loading
Matrix Remodeling Promotes Pulmonary Hypertension through Feedback Mechanoactivation of the YAP/TAZ-miR-130/301 Circuit.
Bertero, Thomas; Cottrill, Katherine A; Lu, Yu; Haeger, Christina M; Dieffenbach, Paul; Annis, Sofia; Hale, Andrew; Bhat, Balkrishen; Kaimal, Vivek; Zhang, Ying-Yi; Graham, Brian B; Kumar, Rahul; Saggar, Rajan; Saggar, Rajeev; Wallace, W Dean; Ross, David J; Black, Stephen M; Fratz, Sohrab; Fineman, Jeffrey R; Vargas, Sara O; Haley, Kathleen J; Waxman, Aaron B; Chau, B Nelson; Fredenburgh, Laura E; Chan, Stephen Y.
Afiliação
  • Bertero T; Divisions of Cardiovascular and Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Cottrill KA; Divisions of Cardiovascular and Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Lu Y; Divisions of Cardiovascular and Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Haeger CM; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Dieffenbach P; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Annis S; Divisions of Cardiovascular and Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Hale A; Divisions of Cardiovascular and Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Bhat B; Regulus Therapeutics, San Diego, CA 92121, USA.
  • Kaimal V; Regulus Therapeutics, San Diego, CA 92121, USA.
  • Zhang YY; Divisions of Cardiovascular and Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Graham BB; Program in Translational Lung Research, University of Colorado, Denver, Aurora, CO 80045, USA.
  • Kumar R; Program in Translational Lung Research, University of Colorado, Denver, Aurora, CO 80045, USA.
  • Saggar R; Departments of Medicine and Pathology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA.
  • Saggar R; Department of Medicine, University of Arizona, Phoenix, AZ 85006, USA.
  • Wallace WD; Departments of Medicine and Pathology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA.
  • Ross DJ; Departments of Medicine and Pathology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA.
  • Black SM; Department of Medicine, University of Arizona, Tuscon, AZ 85724, USA.
  • Fratz S; Department of Pediatric Cardiology and Congenital Heart Disease, DeutschesHerzzentrum München, Klinik an der Technischen Universität München, 80636 Munich, Germany.
  • Fineman JR; Department of Pediatrics, Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA 94131, USA.
  • Vargas SO; Department of Pathology, Boston Children's Hospital, Boston, MA 02115, USA.
  • Haley KJ; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Waxman AB; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Chau BN; Regulus Therapeutics, San Diego, CA 92121, USA.
  • Fredenburgh LE; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Chan SY; Divisions of Cardiovascular and Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. Electronic address: chansy@pitt.edu.
Cell Rep ; 13(5): 1016-32, 2015 Nov 03.
Article em En | MEDLINE | ID: mdl-26565914
ABSTRACT
Pulmonary hypertension (PH) is a deadly vascular disease with enigmatic molecular origins. We found that vascular extracellular matrix (ECM) remodeling and stiffening are early and pervasive processes that promote PH. In multiple pulmonary vascular cell types, such ECM stiffening induced the microRNA-130/301 family via activation of the co-transcription factors YAP and TAZ. MicroRNA-130/301 controlled a PPAR?-APOE-LRP8 axis, promoting collagen deposition and LOX-dependent remodeling and further upregulating YAP/TAZ via a mechanoactive feedback loop. In turn, ECM remodeling controlled pulmonary vascular cell crosstalk via such mechanotransduction, modulation of secreted vasoactive effectors, and regulation of associated microRNA pathways. In vivo, pharmacologic inhibition of microRNA-130/301, APOE, or LOX activity ameliorated ECM remodeling and PH. Thus, ECM remodeling, as controlled by the YAP/TAZ-miR-130/301 feedback circuit, is an early PH trigger and offers combinatorial therapeutic targets for this devastating disease.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Retroalimentação Fisiológica / MicroRNAs / Mecanotransdução Celular / Matriz Extracelular / Hipertensão Pulmonar Limite: Animals / Humans Idioma: En Revista: Cell Rep Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Retroalimentação Fisiológica / MicroRNAs / Mecanotransdução Celular / Matriz Extracelular / Hipertensão Pulmonar Limite: Animals / Humans Idioma: En Revista: Cell Rep Ano de publicação: 2015 Tipo de documento: Article